Helping Clinical Trial Sites Improve Study Recruitment and Retention
HIT Consultant
FEBRUARY 20, 2022
Tzvia Bader, CEO and co-founder, TrialJectory. The clinical trial industry is, once again, at an uncertain crossroads. And while it might be assumed that the outsized impact of the COVID-19 pandemic has resulted in the inability to recruit patients for trials, it is instead, a challenge generated, over time, by the industry itself. Thankfully, there is an opportunity to change course.
Let's personalize your content